Cargando…

The Spectrum of Genetic Defects in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and shows a remarkable heterogeneity in the clinical course. Understand the genetic basis of CLL may help in clarifying the molecular bases of this clinical heterogeneity. Recurrent chromosomal aberrations at 13q14,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Davide, Fangazio, Marco, Gaidano, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2012
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507527/ https://www.ncbi.nlm.nih.gov/pubmed/23205264 http://dx.doi.org/10.4084/MJHID.2012.076

Ejemplares similares

The clinical implications of gene mutations in chronic lymphocytic leukaemia
por: Rossi, Davide, et al.
Publicado: (2016)

Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells
por: Rossi, Francesca M, et al.
Publicado: (2010)

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022)

Precision Medicine Management of Chronic Lymphocytic Leukemia
por: Moia, Riccardo, et al.
Publicado: (2020)

A step ahead toward precision medicine for chronic lymphocytic leukemia
por: Patriarca, Andrea, et al.
Publicado: (2020)

Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
por: Maher, Nawar, et al.
Publicado: (2023)

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
por: Fabbri, Giulia, et al.
Publicado: (2011)

The spectrum of use of rituximab in chronic lymphocytic leukemia
por: Tedeschi, Alessandra, et al.
Publicado: (2010)

Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia
por: Wang, Jiguang, et al.
Publicado: (2014)

Chronic lymphocytic leukemia
por: Rossi, Davide
Publicado: (2018)

T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
por: Vlachonikola, Elisavet, et al.
Publicado: (2021)

Overview of non‐coding mutations in chronic lymphocytic leukemia
por: Spina, Valeria, et al.
Publicado: (2019)

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic
por: Rossi, Davide, et al.
Publicado: (2020)

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy
por: Arruga, Francesca, et al.
Publicado: (2023)

Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia
por: Maffei, Rossana, et al.
Publicado: (2017)

Atypical Chronic Myeloid Leukemia: Where Are We Now?
por: Crisà, Elena, et al.
Publicado: (2020)

Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival
por: Visco, Carlo, et al.
Publicado: (2015)

Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance
por: Dal-Bo, Michele, et al.
Publicado: (2009)

Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ET(A) Receptor
por: Maffei, Rossana, et al.
Publicado: (2014)

Genetic predisposition to chronic lymphocytic leukemia
por: Law, Philip J., et al.
Publicado: (2019)

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation
por: Malcikova, J., et al.
Publicado: (2018)

What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment
por: Laurenti, Luca, et al.
Publicado: (2022)

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
por: Morabito, Fortunato, et al.
Publicado: (2021)

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia
por: Bulian, Pietro, et al.
Publicado: (2012)

Lenalidomide and Chronic Lymphocytic Leukemia
por: González-Rodríguez, Ana Pilar, et al.
Publicado: (2013)

Fludarabine in the treatment of chronic lymphocytic leukemia: a review
por: Ricci, Francesca, et al.
Publicado: (2009)

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy
por: Porrazzo, Marika, et al.
Publicado: (2020)

Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects
por: Manukyan, Gayane, et al.
Publicado: (2017)

Regulatory T-Cells in Chronic Lymphocytic Leukemia and Autoimmune Diseases
por: D’Arena, Giovanni, et al.
Publicado: (2012)

Therapeutic advancement of chronic lymphocytic leukemia
por: Lu, Kang, et al.
Publicado: (2012)

Update in the management of chronic lymphocytic leukemia
por: Maddocks, Kami J, et al.
Publicado: (2009)

Targeted treatment for chronic lymphocytic leukemia
por: Masood, Aisha, et al.
Publicado: (2011)

Apoptosis inducers in chronic lymphocytic leukemia
por: Billard, Christian
Publicado: (2013)

Novel agents for chronic lymphocytic leukemia
por: Wu, Mei, et al.
Publicado: (2013)

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
por: Baliakas, Panagiotis, et al.
Publicado: (2019)

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go
por: Puiggros, Anna, et al.
Publicado: (2014)

Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Robak, Tadeusz, et al.
Publicado: (2022)

Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients
por: Motta, Marina, et al.
Publicado: (2010)

Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia
por: Cortelezzi, Agostino, et al.
Publicado: (2012)

Infectious Complications in Chronic Lymphocytic Leukemia
por: Nosari, Annamaria
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4q1l5pfhncfqv3q7bn1mq2ceod